After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Another busy day on the earnings calendar kept trading erratic again on Thursday, though the S&P 500 and Nasdaq managed to clinch slight gains by the end of the session.
AstraZeneca (AZN) stock is increasing this afternoon after the company reported better-than-expected results before today's market open.
The company's hepatitis C drug division is expected to see losses in the second half of the year.
Trade-Ideas LLC identified AstraZeneca (AZN) as a pre-market leader candidate
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.